Evidence map›Paper›PMID 34560121›Full record

ArticleProgress in cardiovascular diseases

Social vulnerability and COVID-19: An analysis of CDC data.

Mahmoud Al Rifai, Vardhmaan Jain, Safi U Khan, Khurram Nasir, Dongshan Zhu, Rhythm Vasudeva, Carl J Lavie, Sunita Dodani, Laura A Petersen, Salim S Virani

Abstract readLetter
In one paragraph

Article in Progress in cardiovascular diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mahmoud Al RifaiSection of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. Electronic address: rifai@bcm.edu.
Vardhmaan JainDepartment of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.
Safi U KhanDepartment of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, USA.
Khurram NasirDepartment of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, USA.
Dongshan ZhuCentre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan 250012, China; NHC Key Lab of Health Economics and Policy Research, Shandong University, Jinan 250012, China.
Rhythm VasudevaDepartment of Medicine and Pediatrics, University of Kansas School of Medicine- Wichita, Kansas, USA.
Carl J LavieDepartment of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, New Orleans, LA, USA.
Sunita DodaniSection of Cardiology, Department of Internal Medicine, Eastern Virginia Medical School (EVMS), Norfolk, VA, USA; EVMS-Sentara Healthcare Analytics and Delivery Science Institute, Norfolk, VA, USA.
Laura A PetersenHealth Policy, Quality & Informatics Program, Michael E. DeBakey VA Medical Center Health Services, Research & Development Center for Innovations in Quality, Effectiveness, and Safety, Houston, TX, USA; Section of Health Services Research, Baylor College of Medicine, Houston, TX, USA.
Salim S ViraniSection of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Health Policy, Quality & Informatics Program, Michael E. DeBakey VA Medical Center Health Services, Research & Development Center for Innovations in Quality, Effectiveness, and Safety, Houston, TX, USA; Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Section of Cardiology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Centers for Disease Control and Prevention, U.S.HumansSARS-CoV-2Social VulnerabilityUnited States

Identifiers

PMID34560121
PMCPMC8455239

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.